Front & Back Matter.
- Published in:
- Inflammatory Intestinal Diseases, 2021, v. 6, n. 1, p. 1, doi. 10.1159/000515316
- Publication type:
- Article
Works matching IS 22969403 AND DT 2021 AND VI 6 AND IP 1
Results: 7
1
2
Vedolizumab in Inflammatory Bowel Disease: West versus East.
- Published in:
- Inflammatory Intestinal Diseases, 2021, v. 6, n. 1, p. 1, doi. 10.1159/000512805
- By:
- Publication type:
- Article
3
Effect of Originator Infliximab Treatment on Disease-Related Hospitalizations, Work Productivity and Activity Impairment, and Health Resource Utilization in Patients with Crohn's Disease in a Real-Life Setting: Results of a Prospective Multicenter Study in Germany
- Published in:
- Inflammatory Intestinal Diseases, 2021, v. 6, n. 1, p. 48, doi. 10.1159/000512159
- By:
- Publication type:
- Article
4
Clinical Relevance of Anti-TNF Antibody Trough Levels and Anti-Drug Antibodies in Treating Inflammatory Bowel Disease Patients.
- Published in:
- Inflammatory Intestinal Diseases, 2021, v. 6, n. 1, p. 38, doi. 10.1159/000511296
- By:
- Publication type:
- Article
5
Are We Overradiating Patients with Irritable Bowel Syndrome?
- Published in:
- Inflammatory Intestinal Diseases, 2021, v. 6, n. 1, p. 32, doi. 10.1159/000511105
- By:
- Publication type:
- Article
6
Adherence to Recommendations and Quality of Endoscopic Colorectal Cancer Surveillance in Long-Standing Ulcerative Colitis.
- Published in:
- Inflammatory Intestinal Diseases, 2021, v. 6, n. 1, p. 25, doi. 10.1159/000511010
- By:
- Publication type:
- Article
7
Abdominal Surgery in Crohn's Disease: Risk Factors for Complications.
- Published in:
- Inflammatory Intestinal Diseases, 2021, v. 6, n. 1, p. 18, doi. 10.1159/000510999
- By:
- Publication type:
- Article